down arrow

Shaanxi Panlong Pharmaceutical Group Ltd. By Share Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000032C9
CNY
35.62
1.07 (3.1%)

Dec 04

SHE

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Shaanxi Panlong Pharmaceutical Group Ltd. By Share Ltd.
Why is Shaanxi Panlong Pharmaceutical Group Ltd. By Share Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 14.13% and Operating profit at 10.34% over the last 5 years
2
Flat results in Mar 25
  • RAW MATERIAL COST(Y) Grown by 11.34% (YoY)
  • OPERATING PROFIT(Q) Lowest at CNY 27.51 MM
  • OPERATING PROFIT MARGIN(Q) Lowest at 11.12 %
3
With ROE of 7.24%, it has a fair valuation with a 0.88 Price to Book Value
  • Over the past year, while the stock has generated a return of 10.23%, its profits have risen by 3.8% ; the PEG ratio of the company is 3.2
  • At the current price, the company has a high dividend yield of 1.5
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Shaanxi Panlong Pharmaceutical Group Ltd. By Share Ltd. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Shaanxi Panlong Pharmaceutical Group Ltd. By Share Ltd. for you?

Medium Risk, Medium Return

Absolute
Risk Adjusted
Volatility
Shaanxi Panlong Pharmaceutical Group Ltd. By Share Ltd.
22.57%
0.54
30.67%
China Shanghai Composite
14.77%
1.01
15.10%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
14.13%
EBIT Growth (5y)
10.34%
EBIT to Interest (avg)
27.24
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.61
Sales to Capital Employed (avg)
0.60
Tax Ratio
12.77%
Dividend Payout Ratio
26.18%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
20.52%
ROE (avg)
9.45%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
12
Industry P/E
Price to Book Value
0.88
EV to EBIT
4.21
EV to EBITDA
3.20
EV to Capital Employed
0.70
EV to Sales
0.43
PEG Ratio
3.24
Dividend Yield
1.51%
ROCE (Latest)
16.56%
ROE (Latest)
7.24%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

5What is working for the Company
CASH AND EQV(HY)

Highest at CNY 2,335.07 MM

DEBTORS TURNOVER RATIO(HY)

Highest at 2.09%

PRE-TAX PROFIT(Q)

Highest at CNY 36.27 MM

NET PROFIT(Q)

Highest at CNY 31.25 MM

EPS(Q)

Highest at CNY 0.3

-5What is not working for the Company
RAW MATERIAL COST(Y)

Grown by 11.34% (YoY

OPERATING PROFIT(Q)

Lowest at CNY 27.51 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 11.12 %

Here's what is working for Shaanxi Panlong Pharmaceutical Group Ltd. By Share Ltd.
Pre-Tax Profit
Highest at CNY 36.27 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit
Highest at CNY 31.25 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS
Highest at CNY 0.3
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Cash and Eqv
Highest at CNY 2,335.07 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Debtors Turnover Ratio
Highest at 2.09%
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Here's what is not working for Shaanxi Panlong Pharmaceutical Group Ltd. By Share Ltd.
Operating Profit
Lowest at CNY 27.51 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin
Lowest at 11.12 %
in the last five periods
MOJO Watch
Company's profit margin has deteriorated

Operating Profit to Sales

Raw Material Cost
Grown by 11.34% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."